Asarina Pharma AB (OSTO:ASAP) Accounts Payable : kr0.63 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Asarina Pharma AB Accounts Payable?

Asarina Pharma AB's Accounts Payable for the quarter that ended in Dec. 2023 was kr0.63 Mil.

Asarina Pharma AB's quarterly Accounts Payable increased from Dec. 2022 (kr0.84 Mil) to Jun. 2023 (kr1.10 Mil) but then declined from Jun. 2023 (kr1.10 Mil) to Dec. 2023 (kr0.63 Mil).

Asarina Pharma AB's annual Accounts Payable declined from Dec. 2021 (kr2.15 Mil) to Dec. 2022 (kr0.84 Mil) and declined from Dec. 2022 (kr0.84 Mil) to Dec. 2023 (kr0.63 Mil).

Asarina Pharma AB Accounts Payable Historical Data

The historical data trend for Asarina Pharma AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB Accounts Payable Chart

Asarina Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

16.61

11.31

2.15

0.84

0.63

Asarina Pharma AB Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial									2.15	1.00	0.84	1.10	0.63

Asarina Pharma AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Asarina Pharma AB Accounts Payable Related Terms

Thank you for viewing the detailed overview of Asarina Pharma AB's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Asarina Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (OSTO:ASAP) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65

Website

https://www.asarinapharma.com

Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB Headlines

No Headlines